Zhao Ding Selected Research

succinoglycan

2/2022	Dietary Succinoglycan Riclin Improves Glycemia Control in Mice with Type 2 Diabetes.
3/2021	Anti-tumor activity and immunogenicity of a succinoglycan riclin.
12/2019	Oral Administration of Succinoglycan Riclin Improves Diet-Induced Hypercholesterolemia in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhao Ding Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 11/2018
4	Constipation 12/2019 - 06/2011
3	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 01/2021
2	Insulin Resistance 02/2022 - 10/2021
2	Fibrosis (Cirrhosis) 01/2022 - 07/2011
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2018
2	Pouchitis 01/2021 - 05/2019
2	Ulcerative Colitis 01/2021 - 05/2019
1	Anastomotic Leak 02/2022
1	Carcinogenesis 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Obesity 10/2021
1	Hyperglycemia 10/2021
1	Hypothermia 10/2021
1	Sarcoma (Soft Tissue Sarcoma) 03/2021
1	Sarcoma 180 03/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Fatty Liver 01/2021
1	Disease Progression 01/2021
1	Reperfusion Injury 01/2021
1	Infections 04/2020
1	Hypercholesterolemia 12/2019
1	Ischemia 05/2019
1	Adenocarcinoma 11/2018
1	Diarrhea 11/2018
1	Cicatrix (Scar) 12/2012
1	Colonic Neoplasms (Colon Cancer) 06/2011
1	Carcinoma (Carcinomatosis) 06/2011
1	Megacolon 06/2011
1	Colonic Polyps 06/2011
1	Vascular Diseases (Vascular Disease) 01/2008

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 06/2020
3	succinoglycanIBA 02/2022 - 12/2019
3	AntidiarrhealsIBA 12/2019 - 06/2011
1	Streptozocin (Streptozotocin)FDA Link 02/2022
1	Blood Glucose (Blood Sugar)IBA 02/2022
1	pancreatic lipase related protein 2IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	CollagenIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	LipidsIBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2021
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	SuspensionsIBA 05/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Adenine NucleotidesIBA 01/2021
1	salecanIBA 04/2020
1	beta-GlucansIBA 04/2020
1	Food Additives (Food Additive)IBA 12/2019
1	CholesterolIBA 12/2019
1	BilirubinIBA 11/2018
1	Transaminases (Aminotransferases)IBA 11/2018
1	Hemoglobins (Hemoglobin)IBA 11/2018
1	CreatinineIBA 11/2018
1	Monoclonal AntibodiesIBA 08/2015
1	MicroRNAs (MicroRNA)IBA 08/2015
1	Biological ProductsIBA 12/2012
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 07/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2008

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2020
2	Immunotherapy 01/2022 - 06/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2018
2	Restorative Proctocolectomy 01/2021 - 05/2019
2	Transplantation 12/2012 - 07/2011
1	Glycemic Control 02/2022
1	Enterostomy 02/2022
1	Precision Medicine 05/2021
1	Intravenous Injections 01/2021
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021
1	Oral Administration 12/2019
1	Colectomy 12/2019
1	Operative Surgical Procedures 12/2019
1	Stents 11/2018
1	Radiotherapy 11/2018
1	Operative Time 11/2018
1	Neoadjuvant Therapy 11/2018